Literature DB >> 26944087

Dissecting the inflammatory twitch in allergically inflamed mice.

Joshua J Pothen1, Matthew E Poynter1, Lennart K A Lundblad1, Jason H T Bates2.   

Abstract

We have previously advanced the hypothesis that the allergic inflammatory response in the lungs occurs as a self-limited sequence of events that begins with the onset of inflammation and then resolves back to baseline over a predetermined time course (Pothen JJ, Poynter ME, Bates JH. J Immunol 190: 3510-3516, 2013). In the present study we tested a key prediction of this hypothesis, which is that the instigation of the allergic inflammatory response should be accompanied by a later refractory period during which the response cannot be reinitiated. We challenged groups of ovalbumin-sensitized BALB/c mice for 3, 14, 21 and 31 consecutive days with aerosolized ovalbumin. We measured airways responsiveness as well as cell counts and cytokines in bronchoalveolar lavage fluid after the final challenge in subgroups from each group. In other subgroups we performed the same measurements following rest periods and after a final single recall challenge with antigen. We determined that the refractory periods for GM-CSF, KC, and IL-5 are no longer than 10 days, while those for IFNγ and IL-10 are no longer than 28 days. The refractory periods for total leukocytes and neutrophils were no greater than 28 days, while that for eosinophils was more than 28 days. The refractory period for airways resistance was less than 17, while for lung elastance it was longer than 28 days. Our results thus demonstrate that the components of the allergic inflammatory response in the lung have finite refractory periods, with the refractory period of the entire response being in the order of a month.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  bronchoalveolar lavage; cytokines; lung function; refractory period

Mesh:

Substances:

Year:  2016        PMID: 26944087      PMCID: PMC4896098          DOI: 10.1152/ajplung.00036.2016

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  23 in total

1.  CXC chemokines modulate IgE secretion and pulmonary inflammation in a model of allergic asthma.

Authors:  Laura McKinley; Jiyoun Kim; Gerald L Bolgos; Javed Siddiqui; Daniel G Remick
Journal:  Cytokine       Date:  2005-11-14       Impact factor: 3.861

2.  Interleukin-10 does not mediate inhalational tolerance in a chronic model of ovalbumin-induced allergic airway disease.

Authors:  Prakash M Kabbur; William F Carson; Linda Guernsey; Eric R Secor; Roger S Thrall; Craig M Schramm
Journal:  Cell Immunol       Date:  2006-06-12       Impact factor: 4.868

3.  The inflammatory twitch as a general strategy for controlling the host response.

Authors:  Joshua J Pothen; Matthew E Poynter; Jason H T Bates
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

Review 4.  GM-CSF and dendritic cells in allergic airway inflammation: basic mechanisms and prospects for therapeutic intervention.

Authors:  Beata U Gajewska; Ryan E Wiley; Manel Jordana
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2003-12

5.  Pin1-FADD interactions regulate Fas-mediated apoptosis in activated eosinophils.

Authors:  Jiyoung Oh; James S Malter
Journal:  J Immunol       Date:  2013-04-19       Impact factor: 5.422

6.  The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Sireesh Dornadula; Sudheer Pinni; Dileep R Rampa; Raju C Reddy
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

7.  Time course study on the development of allergen-induced airway remodeling in mice: the effect of allergen avoidance on established airway remodeling.

Authors:  H Tanaka; T Masuda; S Tokuoka; Y Takahashi; M Komai; K Nagao; H Nagai
Journal:  Inflamm Res       Date:  2002-06       Impact factor: 4.575

8.  The Temporal Evolution of Airways Hyperresponsiveness and Inflammation.

Authors:  Erik Riesenfeld; Gilman B Allen; Jason Ht Bates; Matthew E Poynter; Min Wu; Steven Aimiand; Lennart Ka Lundblad
Journal:  J Allergy Ther       Date:  2012-01-25

Review 9.  Eosinophil apoptosis as a therapeutic target in allergic asthma.

Authors:  Pinja Ilmarinen; Hannu Kankaanranta
Journal:  Basic Clin Pharmacol Toxicol       Date:  2013-11-13       Impact factor: 4.080

10.  Regulation of adaptive immunity; the role of interleukin-10.

Authors:  T H Sky Ng; Graham J Britton; Elaine V Hill; Johan Verhagen; Bronwen R Burton; David C Wraith
Journal:  Front Immunol       Date:  2013-05-31       Impact factor: 7.561

View more
  2 in total

Review 1.  Pathophysiology to Phenotype in the Asthma of Obesity.

Authors:  Jason H T Bates; Matthew E Poynter; Christa M Frodella; Ubong Peters; Anne E Dixon; Benjamin T Suratt
Journal:  Ann Am Thorac Soc       Date:  2017-11

2.  A theoretical model of inflammation- and mechanotransduction-driven asthmatic airway remodelling.

Authors:  Michael R Hill; Christopher J Philp; Charlotte K Billington; Amanda L Tatler; Simon R Johnson; Reuben D O'Dea; Bindi S Brook
Journal:  Biomech Model Mechanobiol       Date:  2018-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.